163 related articles for article (PubMed ID: 19077459)
1. Proteomic analysis of pancreatic ductal adenocarcinoma compared with normal adjacent pancreatic tissue and pancreatic benign cystadenoma.
Cui Y; Tian M; Zong M; Teng M; Chen Y; Lu J; Jiang J; Liu X; Han J
Pancreatology; 2009; 9(1-2):89-98. PubMed ID: 19077459
[TBL] [Abstract][Full Text] [Related]
2. Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patients.
Tian M; Cui YZ; Song GH; Zong MJ; Zhou XY; Chen Y; Han JX
BMC Cancer; 2008 Aug; 8():241. PubMed ID: 18706098
[TBL] [Abstract][Full Text] [Related]
3. Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry.
Shen J; Person MD; Zhu J; Abbruzzese JL; Li D
Cancer Res; 2004 Dec; 64(24):9018-26. PubMed ID: 15604267
[TBL] [Abstract][Full Text] [Related]
4. Proteomic analysis to identify biomarker proteins in pancreatic ductal adenocarcinoma.
Chung JC; Oh MJ; Choi SH; Bae CD
ANZ J Surg; 2008 Apr; 78(4):245-51. PubMed ID: 18366394
[TBL] [Abstract][Full Text] [Related]
5. Identification of pancreatic juice proteins as biomarkers of pancreatic cancer.
Gao J; Zhu F; Lv S; Li Z; Ling Z; Gong Y; Jie C; Ma L
Oncol Rep; 2010 Jun; 23(6):1683-92. PubMed ID: 20428826
[TBL] [Abstract][Full Text] [Related]
6. Quantitative Proteomic Analysis of Differentially Expressed Protein Profiles Involved in Pancreatic Ductal Adenocarcinoma.
Kuo KK; Kuo CJ; Chiu CY; Liang SS; Huang CH; Chi SW; Tsai KB; Chen CY; Hsi E; Cheng KH; Chiou SH
Pancreas; 2016 Jan; 45(1):71-83. PubMed ID: 26262590
[TBL] [Abstract][Full Text] [Related]
7. [Expression and clinical significance of AHSG and complement C3 in pancreatic ductal adenocarcinoma].
Chen J; Wu W; Chen L; Ma X; Zhao Y; Zhou H; Yang R; Hu L
Zhonghua Yi Xue Za Zhi; 2014 Jul; 94(28):2175-9. PubMed ID: 25331466
[TBL] [Abstract][Full Text] [Related]
8. Comparative proteomic analysis for the detection of biomarkers in pancreatic ductal adenocarcinomas.
Qi T; Han J; Cui Y; Zong M; Liu X; Zhu B
J Clin Pathol; 2008 Jan; 61(1):49-58. PubMed ID: 17412869
[TBL] [Abstract][Full Text] [Related]
9. Application of laser capture microdissection combined with two-dimensional electrophoresis for the discovery of differentially regulated proteins in pancreatic ductal adenocarcinoma.
Shekouh AR; Thompson CC; Prime W; Campbell F; Hamlett J; Herrington CS; Lemoine NR; Crnogorac-Jurcevic T; Buechler MW; Friess H; Neoptolemos JP; Pennington SR; Costello E
Proteomics; 2003 Oct; 3(10):1988-2001. PubMed ID: 14625861
[TBL] [Abstract][Full Text] [Related]
10. Secretin receptors in normal and diseased human pancreas: marked reduction of receptor binding in ductal neoplasia.
Körner M; Hayes GM; Rehmann R; Zimmermann A; Friess H; Miller LJ; Reubi JC
Am J Pathol; 2005 Oct; 167(4):959-68. PubMed ID: 16192632
[TBL] [Abstract][Full Text] [Related]
11. Proteomic and tissue array profiling identifies elevated hypoxia-regulated proteins in pancreatic ductal adenocarcinoma.
Cui Y; Zhang D; Jia Q; Li T; Zhang W; Han J
Cancer Invest; 2009 Aug; 27(7):747-55. PubMed ID: 19488907
[TBL] [Abstract][Full Text] [Related]
12. Twenty-one proteins up-regulated in human H-ras oncogene transgenic rat pancreas cancers are up-regulated in human pancreas cancer.
Yabushita S; Fukamachi K; Kikuchi F; Ozaki M; Miyata K; Sukata T; Deguchi Y; Tanaka H; Kakehashi A; Kawamura S; Uwagawa S; Wanibuchi H; Suzui M; Alexander DB; Tsuda H
Pancreas; 2013 Aug; 42(6):1034-9. PubMed ID: 23648844
[TBL] [Abstract][Full Text] [Related]
13. NBL1 and anillin (ANLN) genes over-expression in pancreatic carcinoma.
Olakowski M; Tyszkiewicz T; Jarzab M; Król R; Oczko-Wojciechowska M; Kowalska M; Kowal M; Gala GM; Kajor M; Lange D; Chmielik E; Gubala E; Lampe P; Jarzab B
Folia Histochem Cytobiol; 2009; 47(2):249-55. PubMed ID: 19995712
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the pancreatic tumor progression by a quantitative proteomic approach and immunhistochemical validation.
Sitek B; Sipos B; Alkatout I; Poschmann G; Stephan C; Schulenborg T; Marcus K; Lüttges J; Dittert DD; Baretton G; Schmiegel W; Hahn SA; Klöppel G; Meyer HE; Stühler K
J Proteome Res; 2009 Apr; 8(4):1647-56. PubMed ID: 19714807
[TBL] [Abstract][Full Text] [Related]
15. Profiling the potential tumor markers of pancreatic ductal adenocarcinoma using 2D-DIGE and MALDI-TOF-MS: up-regulation of Complement C3 and alpha-2-HS-glycoprotein.
Chen J; Wu W; Chen L; Zhou H; Yang R; Hu L; Zhao Y
Pancreatology; 2013; 13(3):290-7. PubMed ID: 23719603
[TBL] [Abstract][Full Text] [Related]
16. Proteome analysis of human pancreatic ductal adenocarcinoma tissue using two-dimensional gel electrophoresis and tandem mass spectrometry for identification of disease-related proteins.
Tian R; Wei LM; Qin RY; Li Y; Du ZY; Xia W; Shi CJ; Jin H
Dig Dis Sci; 2008 Jan; 53(1):65-72. PubMed ID: 17492507
[TBL] [Abstract][Full Text] [Related]
17. Twist, a novel oncogene, is upregulated in pancreatic cancer: clinical implication of Twist expression in pancreatic juice.
Ohuchida K; Mizumoto K; Ohhashi S; Yamaguchi H; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
Int J Cancer; 2007 Apr; 120(8):1634-40. PubMed ID: 17236203
[TBL] [Abstract][Full Text] [Related]
18. Proteomic Identification of FLT3 and PCBP3 as Potential Prognostic Biomarkers for Pancreatic Cancer.
Ger M; Kaupinis A; Petrulionis M; Kurlinkus B; Cicenas J; Sileikis A; Valius M; Strupas K
Anticancer Res; 2018 Oct; 38(10):5759-5765. PubMed ID: 30275197
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA from pancreatic duct aspirate differentiates cystic lesions of the pancreas.
Henry JC; Bassi C; Giovinazzo F; Bloomston M
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S661-6. PubMed ID: 23884752
[TBL] [Abstract][Full Text] [Related]
20. Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies.
Iacobuzio-Donahue CA; Ashfaq R; Maitra A; Adsay NV; Shen-Ong GL; Berg K; Hollingsworth MA; Cameron JL; Yeo CJ; Kern SE; Goggins M; Hruban RH
Cancer Res; 2003 Dec; 63(24):8614-22. PubMed ID: 14695172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]